These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 107337)

  • 21. Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration.
    Hainsworth JD; Grosh WW; Burnett LS; Jones HW; Wolff SN; Greco FA
    Ann Intern Med; 1988 Feb; 108(2):165-70. PubMed ID: 3124679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized comparison of melphalan versus melphalan plus hexamethylmelamine versus adriamycin plus cyclophosphamide in ovarian carcinoma.
    Omura GA; Morrow CP; Blessing JA; Miller A; Buchsbaum HJ; Homesley HD; Leone L
    Cancer; 1983 Mar; 51(5):783-9. PubMed ID: 6401594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation and intensification of a cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin ovarian cancer regimen.
    Bruckner HW; Cohen CJ; Feuer E; Holland JF
    Obstet Gynecol; 1989 Mar; 73(3 Pt 1):349-56. PubMed ID: 2492648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cisplatin-MECY (methotrexate-leucovorin rescue plus cyclophosphamide) versus cisplatin-CHAD (cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin) as initial chemotherapy in stage III-IV ovarian adenocarcinoma.
    Barlow JJ; Lele SB
    Cancer Treat Rep; 1984 Dec; 68(12):1433-8. PubMed ID: 6439408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. cis-Platinum-hexamethylmelamine therapy of advanced ovarian cancer.
    Lopez JA; Krikorian JG; Dias SF; Spiers AS; Finkel HE; Barnard DE
    Gynecol Oncol; 1981 Feb; 11(1):64-7. PubMed ID: 6781990
    [No Abstract]   [Full Text] [Related]  

  • 26. Combination chemotherapy with or without hexamethylmelamine in alkylating-agent resistant ovarian carcinoma.
    Neijt JP; ten Bokkel Huinink WW; van der Burg ME; van Oosterom AT; Kooyman CD; van Houwelingen JC; Pinedo HM
    Cancer; 1984 Apr; 53(7):1467-72. PubMed ID: 6421472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hexamethylmelamine-CAF (cyclophosphamide, methotrexate, and 5-FU) and cisplatin-CAF in refractory ovarian cancer.
    Sessa C; D'Incalci M; Valente I; Bolis G; Colombo N; Mangioni C
    Cancer Treat Rep; 1982 May; 66(5):1233-4. PubMed ID: 6805951
    [No Abstract]   [Full Text] [Related]  

  • 28. Randomised trial comparing two combination chemotherapy regimens (Hexa-CAF vs CHAP-5) in advanced ovarian carcinoma.
    Neijt JP; ten Bokkel Huinink WW; van der Burg ME; van Oosterom AT; Vriesendorp R; Kooyman CD; van Lindert AC; Hamerlynck JV; van Lent M; van Houwelingen JC
    Lancet; 1984 Sep; 2(8403):594-600. PubMed ID: 6147640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapy in advanced ovarian cancer.
    Schein PS
    Geriatrics; 1973 Dec; 28(12):89-95. PubMed ID: 4128004
    [No Abstract]   [Full Text] [Related]  

  • 30. HAC-Cytoxan (cyclophosphamide) chemotherapy for ovarian carcinoma. Alternating chemotherapy with intensification.
    Coleman M; Pasmantier MW; Silver RT
    Cancer; 1985 May; 55(10):2342-7. PubMed ID: 3921228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma.
    Louie KG; Ozols RF; Myers CE; Ostchega Y; Jenkins J; Howser D; Young RC
    J Clin Oncol; 1986 Nov; 4(11):1579-85. PubMed ID: 3095501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclophosphamide plus cis-platinum in combination: treatment program for stage III or IV ovarian carcinoma.
    Decker DG; Fleming TR; Malkasian GD; Webb MJ; Jeffries JA; Edmonson JH
    Obstet Gynecol; 1982 Oct; 60(4):481-7. PubMed ID: 6889714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination chemotherapy for alkylator-resistant ovarian carcinoma: a preliminary report of a Southwest Oncology Group trial.
    Alberts DS; Hilgers RD; Moon TE; Martimbeau PW; Rivkin S
    Cancer Treat Rep; 1979 Feb; 63(2):301-5. PubMed ID: 109200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of advanced ovarian cancer with sequential combination chemotherapy.
    Griffin TW; Hunter RA; Cederbaum AI; Tak WK; Ward AD; Schwartz JH; Halpin TF; Strauss GM; Meyer RN; Liepman MK
    Cancer; 1987 Nov; 60(9):2150-5. PubMed ID: 2830953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. cis-Dichlorodiammineplatinum (II) and hexamethylmelamine in advanced ovarian carcinoma: a phase II study.
    Lund B; Aabo K; Rørth M; Hansen HH
    Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1089-92. PubMed ID: 6819145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of neuropathy in 395 patients with ovarian cancer treated with or without cisplatin.
    van der Hoop RG; van der Burg ME; ten Bokkel Huinink WW; van Houwelingen C; Neijt JP
    Cancer; 1990 Oct; 66(8):1697-702. PubMed ID: 2119878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of leukemia after doxorubicin and cisplatin treatment for ovarian cancer.
    Chambers SK; Chopyk RL; Chambers JT; Schwartz PE; Duffy TP
    Cancer; 1989 Dec; 64(12):2459-61. PubMed ID: 2819655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
    Thigpen T; Vance R; Puneky L; Khansur T
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chemotherapy of advanced epithelial ovarian carcinoma].
    Meerpohl HG
    Onkologie; 1984 May; 7 Suppl 2():22-34. PubMed ID: 6431349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altretamine (hexamethylmelamine) in platinum-resistant and platinum-refractory ovarian cancer: a Gynecologic Oncology Group phase II trial.
    Markman M; Blessing JA; Moore D; Ball H; Lentz SS
    Gynecol Oncol; 1998 Jun; 69(3):226-9. PubMed ID: 9648592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.